European Court of Justice reinforces ruling that crops gene edited via mutagenesis should not be regulated as GMOs

Credit: Transparency International EU Office/Flickr (CC BY-NC-ND 2.0)
Credit: Transparency International EU Office/Flickr (CC BY-NC-ND 2.0)

In-vitro plant gene editing techniques that are used conventionally and have a long safety record are excluded from EU laws restricting the use of genetically modified organisms (GMOs), Europe’s highest court said [February 7].

“Organisms obtained by the in vitro application of a technique/method of mutagenesis which has conventionally been used in a number of in vivo applications and has a long safety record with regard to those applications are excluded from the scope of that directive,” the CJEU said.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Environmentalists, anti-GM groups and farmers have said allowing gene editing would usher in a new era of “GMO 2.0” via the backdoor.

The bioindustry however argued that gene editing could result in hardier and more nutritious crops – as well as offering drug companies new ways to fight human disease.

Read the full CJEU ruling by clicking here.

[Editor’s note: This title has been updated to better reflect the ruling.]

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.